Cannabis-focused biotech company Beleave Inc. (CSE: BE) (OTCQX: BLEVF) this morning announced that, in reference to a previously detailed non-brokered private placement, it has received binding commitments for total proceeds of $5 million at a price of $1.75 per unit. Each unit is comprised of one common share of the company and one-half of one common share purchase warrant, valid for a period of 24 months from the date of issuance with an exercise price of $2.25, subject to certain accelerated expiry conditions. “The company is pleased to welcome a new group of investors, bolster the treasury and add to the companies working capital for future endeavours,” Andrew Wnek, CEO of Beleave, stated in the news release. The offering is subject to customary closing conditions, including CSE approval, but it is expected to close on or about April 26, 2018.
To view the full press release, visit http://cnw.fm/CAAj0
About Beleave
Beleave Inc. is a biotech company and Beleave’s wholly owned subsidiary Beleave Kannabis Corp. (formerly First Access Medical Inc.) is a licensed producer pursuant to the ACMPR. Beleave’s purpose-built facility is located near Hamilton, Ontario. For more information, visit the company’s website at www.Beleave.com
More from CannabisNewsBreaks
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
